Skip to main content
Clinical Trials/NCT02805998
NCT02805998
Completed
N/A

Research on Expecting Moms and Sleep Therapy

University of California, San Francisco1 site in 1 country208 target enrollmentOctober 2016
ConditionsInsomnia

Overview

Phase
N/A
Intervention
Not specified
Conditions
Insomnia
Sponsor
University of California, San Francisco
Enrollment
208
Locations
1
Primary Endpoint
Change in Insomnia Severity Index Scale Score
Status
Completed
Last Updated
last year

Overview

Brief Summary

The overarching goal is to utilize a randomized control design to examine efficacy of web-based cognitive behavior therapy (CBT-I) plus treatment as usual compared to treatment as usual alone for insomnia and depression outcomes among pregnant women with insomnia at high risk for depressive relapse/recurrence (n=208).

Detailed Description

Depression in pregnancy ("antenatal depression") is common and associated with acute and long-lasting adverse consequences for women and offspring. Insomnia is a risk factor for depression in general populations, and poor sleep quality is linked to increased depression among antenatal women. There have been no randomized control trials investigating nonpharmacological insomnia treatment on antenatal insomnia and depression outcomes. Many pregnant women use the Internet to seek pregnancy-related information, and report a preference for mental health care within the home or obstetrics clinic. The overarching goal is to utilize a randomized control design to examine efficacy of web-based cognitive behavior therapy for insomnia and depression outcomes (CBT-I) compared to treatment as usual (TAU) among pregnant women at risk for depression (n=208). Participants will be recruited nationally to complete study questionnaires at five timepoints through pregnancy and 6 months postpartum. Participants randomized to CBT-I will receive access to 6 weekly CBT-I web-sessions and treatment as usual. Participants randomized to treatment as usual will receive usual care and will be given access to Sleepio upon study completion. Our specific aims are: 1. To evaluate feasibility and acceptability of CBT-I for pregnant women. 2. To test whether participants receiving CBT-I show improvement in sleep compared to TAU participants. 3. To examine whether participants randomized to CBT-I will experience improved depressive outcomes compared to TAU. 4. To explore the impact of CBT-I on birth outcomes. There is strong conceptual basis to predict the potential benefit of this approach for pregnant women. Targeting risk factors for antenatal depression may have significant public health benefits.

Registry
clinicaltrials.gov
Start Date
October 2016
End Date
May 2019
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • pregnant up to 28 weeks gestation,
  • 18 years of age or older,
  • Meets Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for Insomnia disorder as determined by the Sleep Condition Indicator (SCI) or Insomnia Severity Index (ISI) score ≥ 11
  • regular access to a web-enabled computer, tablet, or smart phone.

Exclusion Criteria

  • Probable major depression (Edinburgh Postnatal Depression Scale (EPDS) score ≥ 15),
  • self-reported bipolar disorder,
  • self-reported history of psychosis,
  • active suicidality defined as scoring \> 1 on EPDS item 10 or report of a specific suicide plan or recent attempt,
  • shift work employee,

Outcomes

Primary Outcomes

Change in Insomnia Severity Index Scale Score

Time Frame: Baseline to post-intervention (10 weeks post-randomization)

Insomnia Severity Index (ISI). Scores on the ISI range from 0 to 28, with higher scores indicating more severe insomnia.

Secondary Outcomes

  • Change in Percentage of Sleep Efficiency, as Determined by Daily Sleep Logs(Baseline to post-intervention, an average of 8 weeks)
  • Change in Global Sleep Quality, as Determined by Pittsburgh Sleep Quality Index Score(Baseline to post-intervention, an average of 8 weeks)
  • Change in Depression Symptom Severity, as Determined by Edinburgh Postnatal Depression Scale Score(Baseline to post-intervention, an average of 8 weeks)
  • Change in Insomnia Diagnosis, as Determined by Sleep Condition Indicator(Baseline to post-intervention, an average of 8 weeks)
  • Change in Sleep Duration, as Determined by Daily Sleep Logs(Baseline to post-intervention, an average of 8 weeks)

Study Sites (1)

Loading locations...

Similar Trials